Systematic review / meta-analysis / 2015
A systematic review of 12 RCTs suggests saffron may improve symptoms of depression, PMS, sexual dysfunction, and excessive snacking behavior.
A systematic review was conducted to evaluate randomized controlled trials assessing saffron's effects on psychological and behavioral outcomes according to PRISMA guidelines. Twelve studies met the inclusion criteria, covering major depressive disorder (n=6), premenstrual syndrome (n=1), sexual dysfunction and infertility (n=4), and weight loss/snacking behaviors (n=1). Findings supported saffron's efficacy over placebo for improving depressive symptoms (compared to anti-depressants and placebo), premenstrual symptoms, and sexual dysfunction, as well as reducing excessive snacking behavior. The authors concluded that larger multi-site clinical trials are needed to extend these preliminary findings.
- Study type
- Systematic review of randomized controlled trials
- Who was studied
- Human participants across 12 RCTs focusing on psychological/behavioral outcomes
- What was measured
- Depressive symptoms, premenstrual symptoms, sexual dysfunction and infertility, and snacking behaviors
THE PAPER
A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes.
Hausenblas HA, Heekin K, Mutchie HL, Anton S. J Integr Med, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.